drugset / Trial / NCT00256087

The Effect of Prophylactic Probiotic Lactobacilli in Enteral Feeding on Nosocomial Pneumonia Rates in Critically Ill Patients

NCT00256087

Completed 57 enrolled Melbourne Health
RandomizedParallel-groupDouble-blindPrevention

Summary

To assess the effect of addition of probiotic Lactobacilli to standard enteral feeding on infection rates and feeding efficacy in critically ill patients. The study hypothesis is that critically ill patients who receive the addition of probiotic lactobacilli to the enteral feed will lead to a reduced rate of hospital acquired infections. The null hypothesis is that there will be no significant difference in the rate of hospital acquired infection in critically ill patients who receive enteral feeding with or without the addition of probiotic Lactobacilli.

Timeline

Start
2005-01
Primary completion
2010-01
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lactobacillus Fermentum Other / unclassified 2e+11 unknown Other
Comparator Lactobacillus acidophilus Other / unclassified 4e+09 unknown Other

Indications

No indication recorded.